These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1007720)

  • 1. [A study of immunological efficacy of the oral chemical cholera vaccine on experimental animals].
    Dzhaparidze MN; Egorova VD; Karaeva LT; Sumarokov AA; Gor'kova Av
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):115-9. PubMed ID: 1007720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactogenicity and immunological effectiveness of an oral cholera chemical vaccine in a limited controlled experiment with human revaccination].
    Sumarokov AA; Ivanov NR; Lelikov VL; Dzhaparidze MN; Karaeva LT
    Zh Mikrobiol Epidemiol Immunobiol; 1978; (12):87-92. PubMed ID: 371293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.
    Cash RA; Music SI; Libonati JP; Craig JP; Pierce NF; Hornick RB
    J Infect Dis; 1974 Oct; 130(4):325-33. PubMed ID: 4443613
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulation in tablets of a cholera whole cells inactivated vaccine candidate.
    Talavera A; Año G; Pino Y; Castaño J; Uribarri E; Riverón L; Gil S; Fernández S; Cedré B; Valmaseda T; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 Apr; 24(16):3381-7. PubMed ID: 16460846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The determination of the optimal inoculation dose of an oral cholera chemical bivalent vaccine in a controlled experiment].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Reznikov IuB; Rystsova EA; Nikitina GP; Matusevich LIa; Popov AA; Plotnikova MN; Shustov VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):55-62. PubMed ID: 2099071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
    Peterson JW
    Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An oral chemical vaccine from the hypertoxigenic strains of the causative agent of cholera KM-76 Inaba and KM-68 Ogawa].
    Dzhaparidze MN; Naumov AV; Nikitina GP; Meleshchenko MV; Dobrova GV; Zavorotnykh VI; Gracheva VP; Zakharova TL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):31-3. PubMed ID: 1882603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.
    Fernández S; Año G; Castaño J; Pino Y; Uribarri E; Riverón LA; Cedré B; Valmaseda T; Falero G; Pérez JL; Infante JF; García LG; Solís RL; Sierra G; Talavera A
    Travel Med Infect Dis; 2013; 11(2):103-9. PubMed ID: 23492079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity of cholera toxoid in humans.
    Germanier R; Fürer E; Varallyay S; Inderbitzin TM
    J Infect Dis; 1977 Apr; 135(4):512-6. PubMed ID: 856918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a purified cholera toxoid. III. Refinements in purification of toxin and methods for the determination of residual somatic antigen.
    Rappaport RS; Pierzchala WA; Bonde G; McCann T; Rubin BA
    Infect Immun; 1976 Sep; 14(3):687-93. PubMed ID: 823117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomorphologic study of experimental enteric anc combined vaccination against cholera].
    Nazarova LS; Isupov IV; Dzhaparidze MN; Pavlova LP; Gor'kova AV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Nov; (11):78-82. PubMed ID: 160172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic immunity of experimental animals immunized with cholera vaccines].
    Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1994 Sep; 12(12):1078-82. PubMed ID: 7998416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against experimental cholera by antitoxin.
    Pierce NF; Kaniecki EA; Northrup RS
    J Infect Dis; 1972 Dec; 126(6):606-16. PubMed ID: 4664117
    [No Abstract]   [Full Text] [Related]  

  • 19. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
    Sumarokov AA; Ivanov NR; Dzhaparidze MN; Rystsova EA; Reznikov IuB; Matusevich LIa; Nikitina GP; Eliseev IuIu; Adamova GV; Plotnikova MN
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):55-8. PubMed ID: 1719716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.